title: Fair prices for new direct-acting antiviral agents (DAAs) to make treatment for all affordable.
authors.affiliation: Inserm, IAME, UMR 1137, F-75018 Paris, France Univ Paris Diderot, IAME, UMR1137, Sorbonne Paris Cité, F-75018 Paris, France Inserm U995, Univ Lille2-Lille Nord de France, Lille, France.
authors.forename: Sylvie
authors.initials: S
authors.lastname: Deuffic-Burban
authors.affiliation: Inserm, IAME, UMR 1137, F-75018 Paris, France Univ Paris Diderot, IAME, UMR1137, Sorbonne Paris Cité, F-75018 Paris, France Service de Maladies infectieuses et tropicales, Hôpital Bichat Claude Bernard, Paris, France.
authors.forename: Yazdan
authors.initials: Y
authors.lastname: Yazdanpanah
mesh_terms: D016527:Drug Costs; D017048:Health Care Costs / Q000706:statistics & numerical data*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D014542:Uridine Monophosphate / Q000031:analogs & derivatives*
chemical_list: D014542:Uridine Monophosphate
keywords: CHRONIC VIRAL HEPATITIS; COST-EFFECTIVENESS; DECISION ANALYSIS; HEALTH ECONOMICS; HEPATITIS C